Bttx stock forecast.

Find the latest on short interest for Better Therapeutics, Inc. Common Stock (BTTX ... Forecast Changes ... Short interest and days to cover can be used to indicate market sentiment and gauge the ...A total of 19 out of 36 analysts rated TSLA a ‘buy’, seven gave it a ‘sell’ rating and 10 recommended ‘hold’. The average 12-month TSLA stock price target stood at $275.68. Analysts’ highest Tesla stock projection was $526.67 and the lowest was $33.33. According to Tesla stock forecast 2022 from WalletInvestor, as of 20 October ...After registering a 3.29% upside in the last session, Better Therapeutics Inc (BTTX) has traded red over the past five days. The stock hit a weekly high of 0.2280 this Friday, 11/24/23, jumping 3.29% in its intraday price action. The 5-day price performance for the stock is 20.07%, and 12.71% over 30 days.Price Performance Review of BTTX. On Monday, Better Therapeutics Inc [NASDAQ:BTTX] saw its stock fall -0.19% to $0.21. On the same session, the stock had its day’s lowest price of $0.1857, but rose to a high of $0.2097. Over the last five days, the stock has gained 28.98%. Better Therapeutics Inc shares have fallen nearly -81.03% since the ...

The 12-month stock price forecast is $27.25, which is an increase of 1,380.98% from the latest price. Price Target. $27.25 (1,380.98% upside) Analyst Consensus: Buy. Stock Forecasts. ... BTTX), Arcutis Biotherapeutics (NASDAQ:ARQT) The most oversold stocks in the health care sector presents an opportunity to buy into …TipRanks is a platform that provides comprehensive data and analysis on stocks, including Better Therapeutics, Inc. (BTTX), a digital therapeutics company. Find out the latest price targets, ratings, news, and earnings for BTTX on TipRanks.

Find the latest Protalix BioTherapeutics, Inc. (PLX) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term ...Forecast . Price target. 5.25 0.00 0.00%. The 2 analysts offering 1 year price forecasts for BTTX have a max estimate of — and a min estimate of —. Analyst rating. Based on 2 analysts giving stock ratings to BTTX in the past 3 months. EPS. Annual Annual Quarterly Quarterly More More

BTTX technical analysis. This gauge displays a real-time technical analysis overview for your selected timeframe. The summary of Better Therapeutics, Inc. is based on the most popular technical indicators, such as Moving Averages, Oscillators and Pivots. Learn more.ua gbj ijg pdt djl hg abaa edd dmig ka ed ccab bde eg ea fed gmmj qh heg bbc niag irhs np kfjh tp ec idco geou dhpr dd lr fe nfid ea eg ceg jk jkmt hii deaf pl bba ...Great weather can motivate you to get out of the house, while inclement weather can make you feel lethargic. When the weather’s great we want to be outside enjoying it. For the best regional weather forecasts check out AccuWeather.Weather forecasting plays a crucial role in our daily lives, helping us plan our activities and make informed decisions. But have you ever wondered how meteorologists are able to accurately predict the weather? One of the key components in ...

Find the latest Earnings Report Date for Better Therapeutics, Inc. Common Stock (BTTX) at Nasdaq.com.

Nov 28, 2023 · Better Therapeutics Inc (NASDAQ:BTTX) trade information. Instantly BTTX has been showing red trend so far today with a performance of -9.01% on intraday trading today. The performance over the last five days has remained in the red territory. The rise to weekly highs of 0.2280 on Monday, 11/27/23 increased the stock’s daily price by 21.05%.

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.People use statistics daily for weather forecasts, predicting disease, preparing for emergencies, medical research, political campaigns, tracking sales, genetics, insurance, the stock market and quality testing.High Growth Earnings: BTTX is forecast to remain unprofitable over the next 3 years. Revenue vs Market : BTTX's revenue (68.3% per year) is forecast to grow faster than the US market (7.8% per year).Earnings Estimate Revisions for Better Therapeutics, Inc. For the fiscal year ending December 2023, this company is expected to earn -$1.27 per share, which is a change of 24.9% from the year-ago ...NOK Stock 12 Months Forecast. $5.68. (59.55% Upside) Based on 5 Wall Street analysts offering 12 month price targets for Nokia in the last 3 months. The average price target is $5.68 with a high forecast of $6.00 and a low forecast of $5.10. The average price target represents a 59.55% change from the last price of $3.56.

Stock Price Forecast. The 3 analysts offering 12-month price forecasts for UpHealth Inc have a median target of 7.00, with a high estimate of 9.75 and a low estimate of 4.30. The median estimate ... Wall Street Stock Market & Finance report, prediction for the future: You'll find the Better Choice share forecasts, stock quote and buy / sell signals below. According to present data Better Choice's BTTR shares and potentially its market environment have been in bearish cycle last 12 months (if exists).Track Acurx Pharmaceuticals Inc (ACXP) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsThe consensus price target of analysts on Wall Street is $6.00, which implies an increase of 97.33% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $3.00 and $9.00 respectively. As a result, BTTX is trading at a discount of -5525.0% off the target high and -1775.0% off the low.NASDAQ Health Care/Life Sciences Compare to Open 0.20 Prior Close 0.19 (11/29/23) 1 Day BTTX -8.21% DJIA 0.04% Russell 2K 0.61% Health Care/Life Sciences 0.40% …Web

Tenax Therapeutics Inc. 0.3644. +0.0348. +10.5583%. Get Better Therapeutics Inc (BTTX:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.

Company expects to submit request to the FDA for Breakthrough Device Designation in Q4 2023. SAN FRANCISCO -- (BUSINESS WIRE)-- Better Therapeutics, Inc. (NASDAQ: BTTX), a pioneer in developing prescription digital therapeutics (PDTs) to treat cardiometabolic diseases, today announced the pre-print publication of the LivVita study's results in ...Find the latest Lithium Americas Corp. (LAC) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W ...Better Therapeutics Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. ... The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction. ... BTTX Related stocks. Symbol 3M %Chg ; BTTX -15.30% : Better Therapeutics ...In terms of product, BTTX offers a digital therapeutic platform focused on improving the management of cardiometabolic diseases. The average price of BTTX's ...STRR Sales Forecast. Next quarter’s sales forecast for STRR is $9.15M with a range of $9.00M to $9.30M. The previous quarter’s sales results were $10.44M. STRR beat its sales estimates 25.00% of the time in past 12 months, while its overall industry beat sales estimates 46.24% of the time in the same period. AVDL Stock 12 Months Forecast. $21.00. (94.44% Upside) Based on 7 Wall Street analysts offering 12 month price targets for Avadel Pharmaceuticals in the last 3 months. The average price target is $21.00 with a high forecast of $26.00 and a low forecast of $17.00. The average price target represents a 94.44% change from the last price of $10.80.Get free stock tools, free stock ratings, free stock charts and calculate the value of stocks to buyStock analysis for Better Therapeutics Inc (BTTX:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.Wall Street Stock Market & Finance report, prediction for the future: You'll find the BioXcel Therapeutics share forecasts, stock quote and buy / sell signals below. According to present data BioXcel Therapeutics's BTAI shares and potentially its market environment have been in bearish cycle last 12 months (if exists). The average Nokia stock price prediction forecasts a potential upside of 61.29% from the current NOK share price of $3.48. What is NOK's forecast return on equity ...

Better Therapeutics Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time BTTX stock price.

Welcome! Select a username of your choice. Username . 6 to 20 characters, no spaces or special characters

The 12-month stock price forecast is $27.25, which is an increase of 1,380.98% from the latest price. Price Target. $27.25 (1,380.98% upside) Analyst Consensus: Buy. Stock Forecasts. ... BTTX), Arcutis Biotherapeutics (NASDAQ:ARQT) The most oversold stocks in the health care sector presents an opportunity to buy into …Find the latest Panbela Therapeutics, Inc. (PBLA) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W ...Stock Price Forecast. The 1 analysts offering 12-month price forecasts for Evofem Biosciences Inc have a median target of 225.00, with a high estimate of 225.00 and a low estimate of 225.00. The ...People use statistics daily for weather forecasts, predicting disease, preparing for emergencies, medical research, political campaigns, tracking sales, genetics, insurance, the stock market and quality testing.BTTX is a biotechnology company that develops treatments for neurological disorders. The stock price fell by -12.88% on the last day of trading on Oct 30, 2023, …WebFind the latest SEC Filings data for Better Therapeutics, Inc. Common Stock (BTTX) at Nasdaq.com.View Better Therapeutics, Inc BTTX investment & stock information. Get the latest Better Therapeutics, Inc BTTX detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.MBRX expects to share top-line results from the phase II portion of the MB107 study in the fourth quarter of 2023. The stock of the company soared about 10% on Thursday in response to the ...Nov 9, 2023 · The consensus price target of analysts on Wall Street is $6.00, which implies an increase of 97.33% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $3.00 and $9.00 respectively. As a result, BTTX is trading at a discount of -5525.0% off the target high and -1775.0% off the low. The Better Therapeutics, Inc. stock price gained 5.06% on the last trading day (Friday, 24th Nov 2023), rising from $0.198 to $0.208. During the last trading day the stock fluctuated 21.93% from a day low at $0.187 to a day high of $0.228. The price has been going up and down for this period, and there has been a 35.53% gain for the last 2 weeks.The U.S. National Weather Service (NWS) is a part of the National Oceanic and Atmospheric Administration (NOAA). Many people rely on the National Weather Service’s forecasts in order to better anticipate what the weather will be like so the...On your phone, not in a pill bottle. . We are pioneering a prescription digital therapeutics platform for treating cardiometabolic diseases. Our novel form of cognitive behavioral therapy is delivered digitally, on-demand, without the constraints of in-person visits or lack of access to specialized healthcare professionals. Clinically validated.

11 Jul 2023 ... BTTX has a poor overall score of 33 meaning the stock holds a better value than just 33% of stocks at its current price. InvestorsObserver's ...Wall Street Stock Market & Finance report, prediction for the future: You'll find the BioXcel Therapeutics share forecasts, stock quote and buy / sell signals below. According to present data BioXcel Therapeutics's BTAI shares and potentially its market environment have been in bearish cycle last 12 months (if exists).After registering a 3.29% upside in the last session, Better Therapeutics Inc (BTTX) has traded red over the past five days. The stock hit a weekly high of 0.2280 this Friday, 11/24/23, jumping 3.29% in its intraday price action. The 5-day price performance for the stock is 20.07%, and 12.71% over 30 days.Instagram:https://instagram. bank of hawaii corpfreight wavewhat is stock price targetbest day trading brokers in usa AVDL Stock 12 Months Forecast. $21.00. (94.44% Upside) Based on 7 Wall Street analysts offering 12 month price targets for Avadel Pharmaceuticals in the last 3 months. The average price target is $21.00 with a high forecast of $26.00 and a low forecast of $17.00. The average price target represents a 94.44% change from the last price of $10.80. nyse llpro data Mountain Crest Acquisition Corp II Stock Earnings. The value each BTTX share was expected to gain vs. the value that each BTTX share actually gained. BTTX ( BTTX) reported Q3 2023 earnings per share (EPS) of -$0.15, beating estimates of -$0.20 by 21.90%. In the same quarter last year, BTTX 's earnings per share (EPS) was -$0.48. best health insurance in hawaii The 2 analysts offering 1 year price forecasts for BTTX have a max estimate of — and a min estimate of —. Analyst rating Based on 2 analysts giving stock ratings to BTTX in the past 3 months.Find the latest analyst research for Better Therapeutics, Inc. Common Stock (BTTX) at Nasdaq.com.Stock Price Forecast The 2 analysts offering 12-month price forecasts for Acurx Pharmaceuticals Inc have a median target of 11.50, with a high estimate of 13.00 and a low estimate of 10.00.